Study types
- article 10
- other 2
- review 2
Condition tags
- endometriosis 8
- dysmenorrhea 1
- adenomyosis 1
Top journals
Frequent coauthors
INTRODUCTION: Although several studies suggest beneficial effects of low-dose estrogen-progestins (LEPs) and progestins on dysmenorrhea in Japanese women, the difference in efficacy between drugs remains unknown. METHODS: We identified stud…
OBJECTIVE: C-C motif chemokine ligand 20 is thought to contribute to the development of endometriosis by recruiting Th17 lymphocytes into endometriotic foci. The present study investigated the effects of dienogest, a progesterone receptor a…
OBJECTIVES: To investigate the direct effects of progesterone receptor (PR) agonists on proliferation and apoptosis of human adenomyotic cells. STUDY DESIGN: Human primary cultures of adenomyotic stromal cells (ASCs) from 24 patients with …
BACKGROUND: We aimed to establish an endometrial autograft model in rats that would allow for repetitive in vivo analyses of angiogenesis. Dienogest (DNG) is an orally active progestin used for the treatment of endometriosis. We investigate…
Dienogest is a specific progesterone receptor agonist with potent oral endometrial activity and is used in the treatment of endometriosis. In this study, we examined the direct effects of dienogest on the proliferation of human endometrial …
ジエノゲスト(販売名:ディナゲスト錠1 mg)は,プロゲステロン受容体に対して選択的なアゴニスト活性を示す第4世代のプロゲスチンである.ジエノゲストは,ラットおよびウサギに経口投与することによりプロゲステロン作用を示し,一方,アンドロゲン作用,グルココルチコイド作用およびミネラルコルチコイド作用は示さなかった.ジエノゲストは,カニクイザルに反復経口投与することにより月経周期の停止,月経周期に伴う血中エストラジオール濃度の上昇および黄体形成ホルモン濃度の上昇を抑制し,卵巣機能抑…